Evidence that calcineurin is rate-limiting for primary human lymphocyte activation

Journal of Clinical Investigation

Volumn 100, Issue 7, 1997, Pages 1894-1901

  Batiuk, Thomas O ^a,c   Kung, Lina ^a   Halloran, Philip F ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Division of Nephrology   (Canada)

^c INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Calcineurin; Cyclosporine; Immunosuppression; Lymphocytes; Signal transduction

Indexed keywords

CALCINEURIN; CYCLOSPORIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; MESSENGER RNA; NUCLEAR FACTOR;

ARTICLE; ENZYME ACTIVITY; GENE ACTIVATION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0030931934     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119719     Document Type: Article

References (60)

1. Hsu, V.L., and I.M. Armitage. 1992. Solution structure of cyclosporin A and a nonimmunosuppressive analog bound to fully deuterated cyclophilin. Biochemistry. 31:12778-12784.
2. Pflugl, G., J. Kallen, T. Schirmer, J.N. Jansonius, M.G.M. Zurini, and M.D. Walkinshaw. 1993. X-ray structure of a decameric cyclophilin-cyclosporin crystal complex. Nature (Lond.). 361:91-94.
3. Thériault, Y., T.M. Logan, R. Meadows, L. Yu, E.T. Olejniczak, T.F. Holzman, R.L. Simmer, and S.W. Fesik. 1993. Solution structure of the cyclosporine A/cyclophilin complex by NMR. Nature (Lond.). 361:88-91.
4. Clipstone, N.A., and G.R. Crabtree. 1992. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature (Lond.). 357:695-697.
5. Foor, F., S.A. Parent, N. Morin, A.M. Dahl, N. Ramadan, G. Chrebet, K.A. Bostian, and J.B. Nielsen. 1992. Calcineurin mediates inhibition by FK506 and cyclosporin of recovery from α-factor arrest in yeast. Nature (Lond.). 360: 682-684.
6. Schreiber, S.L., and G.R. Crabtree. 1992. The mechanism of action of cyclosporin A and FK506. Immunol. Today. 13:136-142.
7. Harding, M.W., A. Galat, D.E. Uehling, and S.L. Schreiber. 1989. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature (Lond.). 341:758-760.
8. Kay, J.E., C.R. Benzie, M.R. Goodier, C.J. Wick, and S.E.A. Doe. 1989. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506. Immunology. 67:473-477.
9. Shaw, K.T.-Y., A.M. Ho, A. Raghavan, J. Kim, J. Jain, J. Park, S. Sharma, A. Rao, and P.G. Hogan. 1995. Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc. Natl. Acad. Sci. USA. 92:11205-11209.
10. McCaffrey, P.G., C. Luo, T.K. Kerppola, J. Jain, T.M. Badalian, A.M. Ho, E. Burgeon, W.S. Lane, J.N. Lambert, T. Curran, et al. 1993. Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science (Wash. DC). 262:750-754.
11. p is a substrate for calcineurin and interacts with Fos and Jun. Nature (Lond.). 365: 352-355.
12. Northrop, J.P., S.N. Ho, L. Chen, D.J. Thomas, L.A. Timmerman, G.P. Nolan, A. Admon, and G.R. Crabtree. 1994. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature (Lond.). 369: 497-502.
13. Ullman, K.S., J.P. Northrop, A. Admon, and G.R. Crabtree. 1993. Jun family members are controlled by a calcium-regulated, cyclosporin A-sensitive signaling pathway in activated T lymphocytes. Genes Drv. 7:188-196.
14. Rincón, M., and R.A. Flavell. 1994. AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO (Eur. Mol. Biol. Organ.) J. 13:4370-4381.
15. Su, B., E. Jacinto, M. Hibi, T. Kallunki, M. Karin, and Y. Ben-Neriah. 1994. JNK is involved in signal integration during costimulation of T lymphocytes. Cell. 77:727-736.
16. 2+ influx. Functional synergy between Raf and calcineurin. J. Immunol. 157:5277-5283.
17. Frantz, B., E.C. Nordby, G. Bren, N. Steffan, C.V. Paya, R.L. Kincaid, M.J. Tocci, S.J. O'Keefe, and E.A. O'Neill. 1994. Calcineurin acts in synergy with PMA to inactivate IκB/MAD3, an inhibitor of NF-κB. EMBO (Eur. Mol. Biol. Organ.) J. 13:861-870.
18. Nolan, G.P. 1994. NF-AT-AP-1 and Rel-bZIP: hybrid vigor and binding under the influence. Cell. 77:795-798.
19. ras and calcineurin synergize to regulate the nuclear factor of activated T cells. J. Exp. Med. 178:1517-1522.
20. Rao, A. 1995. NFATp, a cyclosplorin-sensitive transcription factor implicated in cytokine gene induction. J. Leukocyte Biol. 57:536-542.
21. Fuleihan, R., N. Ramesh, A. Horner, D. Ahern, P.J. Belshaw, D.G. Alberg, I. Stamenkovic, W. Harmon, and R.S. Geha. 1994. Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J. Clin. Invest. 93:1315-1320.
22. O'Keefe, S.J., J. Tamura, R.L. Kincaid, M.J. Tocci, and E.A. O'Neill. 1992. FK-506 and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature (Lond.). 357:692-694.
23. Liu, J., M.W. Albers, T.J. Wandless, S. Luan, D.G. Alberg, P.J. Belshaw, P. Cohen, C. MacKintosh, C.B. Kless, and S.L. Schreiber. 1992. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry. 31:3896-3901.
24. Zhang, W., G. Zimmer, J. Chen, D. Ladd, E. Li, F.W. Alt, G. Wiederrecht, J. Cryan, E.A. O'Neill, C.E. Seidman, et al. 1996. T cell responses in calcineurin A-deficient mice. J. Exp. Med. 183:413-420.
25. Batiuk, T.D., F. Pazderka, and P.F. Halloran. 1995. Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients. Transplantation (Baltimore). 59:1400-1404.
26. Pai, S.Y., D.A. Fruman, T. Leong, D. Neuberg, T.G. Rosano, C. McGarigle, J.H. Antin, and B.E. Bierer. 1994. Inhibition of calcineurin phosphatase activity in adult bone marrow transplant patients treated with cyclosporine A. Blood 84:3974-3979.
27. Batiuk, T.D., F. Pazderka, J. Enns, L. DeCastro, and P.F. Halloran. 1995. Cyclosporine inhibition of calcineurin activity in human leukocytes in vivo is rapidly reversible. J. Clin. Invest. 96:1254-1260.
28. Quien, R.M., B.A. Kaiser, S.P. Dunn, A. Kulinsky, M. Polinsky, H.J. Baluarte, T.D. Batiuk, and P.F. Halloran. 1997. Calcineurin activity in children with renal transplants receiving cyclosporine. Transplantation (Baltimore). In press.
29. 50 for in vivo cyclosporine in mouse. Transplantation (Baltimore). 61:1618-1624.
30. Fruman, D.A., C.B. Klee, B.E. Bierer, and S.J. Burakoff. 1992. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc. Natl. Acad. Sci. USA. 89:3686-3690.
31. Batiuk, T.D., F. Pazderka, J. Enns, L. DeCastro, and P.F. Halloran. 1996. Cyclosporine inhibition of leukocyte calcineurin is much less in whole blood than in culture medium. Transplantation (Baltimore). 61:158-161.
32. Kaye, R.E., D.A. Fruman, B.E. Bierer, M.W. Albers, L.D. Zydowsky, S.I. Ho, Y.J. Jin, M.C. Castells, S.L. Schreiber, C.T. Walsh, et al. 1992. Effects of cyclosporin A and PK506 on Fcγ receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12. Proc. Natl. Acad. Sci. USA. 89:8542-8546.
33. Campbell, P.M., J. Pimm, V. Ramassar, and P.F. Halloran. 1996. Identification of a calcium inducible, cyclosporine-sensitive element in the IFN-γ promoter that is a potential NFAT binding site. Transplantation (Baltimore). 61: 933-939.
34. 33a. Abe, E., R. De Waal Malefyt, I. Matsuda, K. Arai, and N. Arai. 1992. An 11-base-pair DNA sequence motif apparently unique to the human interleukin 4 gene confers responsiveness to T-cell activation signals. Proc. Natl. Acad. Sci. USA. 89:2864-2868.
35. Maniatis, T., E.F. Fritsch, and J. Sambrook. 1982. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. 196 pp.
36. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
37. Thomas, P.S. 1980. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA. 77:5201-5205.
38. Pazderka, F., J. Enns, T.D. Batiuk, and P.F. Halloran. 1996. The functional consequences of partial calcineurin inhibition in human peripheral blood mononuclear leucocytes. Transpl. Immunol. 4:23-31.
39. Mosmann, T.R., and R.L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 10:145-173.
40. Mosmann, T.R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17:138-146.
41. Kelso, A. 1995. Th1 and Th2 subsets: paradigms lost? Immunol. Today. 16:374-379.
42. Voss, S.D., R. Hong, and P.M. Sondel. 1994. Severe combined immunodeficiency, interleukin-2 (IL-2), and the IL-2 receptor: experiments of nature continue to point the way. Blood. 83:626-635.
43. Macchi, P., A. Villa, S. Gillani, M.G. Sacco, A. Frattini, F. Porta, A.G. Ugazio, J.A. Johnston, F. Candotti, J.J. O'Shea, et al. 1995. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature (Lond.). 377:65-68.
44. Russell, S.M., N. Tayebi, H. Nakajima, M.C. Riedy, J.L. Roberts, M.J. Aman, T.-S. Migone, M. Noguchi, M.L. Markert, R.H. Buckley, et al. 1995. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science (Wash. DC). 270:797-800.
45. Elder, M.E., D. Lin, J. Clever, A.C. Chan, T.J. Hope, A. Weiss, and T.G. Parslow. 1994. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science (Wash. DC). 264:1596-1599.
46. Chan, A.C., T.A. Kadlecek, M.E. Elder, A.H. Filipovich, W.L. Kuo, M. Iwashima, T.G. Parslow, and A. Weiss. 1994. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science (Wash. DC). 264:1599-1601.
47. Leitges, M., C. Schmedt, R. Guinamard, J. Davoust, S. Schaal, S. Stabel, and A. Tarakhovsky. 1996. Immunodeficiency in protein kinase Cβ-deficient mice. Science (Wash. DC). 273:788-791.
48. Henkemeyer, M., D.J. Rossi, D.P. Holmyard, M.C. Puri, G. Mbamalu, K. Harpai, T.S. Shih, T. Jacks, and T. Pawson. 1995. Vascular system defects and neuronal apoptosis in mice lacking Ras GTPase-activating protein. Nature (Lond.). 377:695-701.
49. Umanoff, H., W. Edelmann, A. Pellicer, and R. Kucherlapati. 1995. The murine N-ras gene is not essential for growth and development. Proc. Natl. Acad. Sci. USA. 92:1709-1713.
50. Shahinian, A., K. Pfeffer, K.P. Lee, T.M. Kündig, K. Kishihara, A. Wakeham, K. Kawai, P.S. Ohashi, C.B. Thompson, and T.W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science (Wash. DC). 261:609-612.
51. Green, J.M., P.J. Noel, A.I. Sperling, T.L. Walunas, G.S. Gray, J.A. Bluestone, and C.B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity. 1:501-508.
52. Kawai, K., A. Shahinian, T.W. Mak, and P.S. Ohashi. 1996. Skin allograft rejection in CD28-deficient mice. Transplantation (Baltimore). 61:352-355.
53. Shibasaki, F., E.R. Price, D. Milan, and F. McKeon. 1996. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature (Lond.). 382:370-373.
54. von Graffenried, B., and W.B. Harrison. 1993. Side effects (with emphasis on renal dysfunction) and recommendations for use. In Ciclosporin in Autoimmune Diseases. R. Schindler, editor. Springer-Verlag, Berlin/Heidelberg. 60-73.
55. Koyama, H., and J.M. Cecka. 1992. Rejection episodes. In Clinical Transplants. P.I. Terasaki and J.M. Cecka, editors. UCLA Tissue Typing Laboratory, Los Angeles. 391-404.
56. Halloran, P.F., P. Autenried, and A. Wadgymar. 1986. Regulation of HLA antigen expression in human kidney. Clinics in Immunology and Allergy. 6:411-435.
57. Palestine, A.G., F. Roberge, B.L. Charous, H.C. Lane, A.S. Fauci, and R.B. Nussenblatt. 1985. The effect of cyclosporine on immunization with tetanus and keyhole limpet hemocyanin (KLH) in humans. J. Clin. Immunol. 5: 115-121.
58. Kahan, B.D. 1989. Cyclosporine. N. Engl. J. Med. 321:1725-1738.
59. Fathman, C.G., and B.D. Myers. 1992. Cyclosporine therapy for autoimmune disease. N. Engl. J. Med. 326:1693-1695.
60. Langman, L.J., D.F. LeGatt, P.F. Halloran, and R.W. Yatscoff. 1996. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients. Transplantation (Baltimore). 62:666-672.